TNF and inflammatory bowel disease: Furthermore, a recent study from the Israeli IBD research nucleus revealed that the risk of ADA development can be increased in IBD patients exposed to cephalosporins or penicillin with β-lactamase inhibitors before or during anti-TNF therapy, while the treatment with fluoroquinolones or macrolides can possibly minimize the risk (Gorelik et al., 2022).